LYNN A. TETRAULT - 01 Jun 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Jun 2024
Net transactions value
$0
Form type
4
Filing time
04 Jun 2024, 16:10:34 UTC
Previous filing
06 Mar 2024
Next filing
11 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEO Common Stock 50,062 01 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +8,672 $0.000000 8,672 01 Jun 2024 Common Stock 8,672 $13.71 Direct
transaction NEO Restricted Stock Unit Award $0 +12,254 $0.000000 12,254 01 Jun 2024 Common Stock 12,254 $0.000000 Direct F1
holding NEO Stock Option (Right to Buy) 2,136 01 Jun 2024 Common Stock 2,136 $22.52 Direct
holding NEO Stock Option (Right to Buy) 3,448 01 Jun 2024 Common Stock 3,448 $28.54 Direct
holding NEO Stock Option (Right to Buy) 3,714 01 Jun 2024 Common Stock 3,714 $40.90 Direct
holding NEO Stock Option (Right to Buy) 972 01 Jun 2024 Common Stock 972 $41.76 Direct
holding NEO Stock Option (Right to Buy) 13,882 01 Jun 2024 Common Stock 13,882 $8.10 Direct
holding NEO Stock Option (Right to Buy) 8,353 01 Jun 2024 Common Stock 8,353 $14.82 Direct
holding NEO Restricted Stock Unit 11,336 01 Jun 2024 Common Stock 11,336 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.